.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Argus Health
US Department of Justice
Johnson and Johnson
QuintilesIMS
Novartis
Teva
Mallinckrodt
US Army
Farmers Insurance

Generated: June 26, 2017

DrugPatentWatch Database Preview

BENZTROPINE MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Benztropine Mesylate, and when can generic versions of Benztropine Mesylate launch?

Benztropine Mesylate is a drug marketed by Upsher-smith Labs, Oxford Pharms, Quantum Pharmics, Usl Pharma, Aspen Global Inc, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Epic Pharma Llc, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, and Invagen Pharms. and is included in twenty-seven NDAs.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are five drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

Summary for Tradename: BENZTROPINE MESYLATE

Patents:0
Applicants:16
NDAs:27
Suppliers / Packagers: see list33
Bulk Api Vendors: see list62
Clinical Trials: see list529
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BENZTROPINE MESYLATE at DailyMed

Pharmacology for Tradename: BENZTROPINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leading Pharma Llc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL090168-003Nov 28, 2012AARXNoNo► Subscribe► Subscribe
Frontida Biopharm
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL081265-001Jan 23, 1992DISCNNoNo► Subscribe► Subscribe
Lannett Holdings Inc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088877-001Apr 11, 1985DISCNNoNo► Subscribe► Subscribe
Epic Pharma Llc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL072266-001Feb 27, 1989AARXNoNo► Subscribe► Subscribe
Upsher-smith Labs
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL040103-001Dec 12, 1996AARXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Fish and Richardson
AstraZeneca
Baxter
Cerilliant
Fuji
Accenture
Cipla
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot